TY  - JOUR
AU  - Garcia-Robles, Ana
AU  - Gimeno Navarro, Ana
AU  - Serrano Martin, Maria Del Mar
AU  - Parraga Quiles, Maria Jose
AU  - Parra Llorca, Anna
AU  - Poveda-Andres, Jose Luis
AU  - Vento Torres, Maximo
AU  - Aguar Carrascosa, Marta
PY  - 2020
DO  - 10.3389/fped.2020.00372
SN  - 2296-2360
UR  - http://hdl.handle.net/10668/16067
T2  - Frontiers in pediatrics
AB  - Background: Currently, the first line treatment of persistent ductus arteriosus (PDA) is either indomethacin or ibuprofen. However, the potentially life-threatening side effects associated to their use have prompted physicians to look for alternative...
LA  - en
PB  - Frontiers Research Foundation
KW  - Ductus
KW  - Efficacy
KW  - Paracetamol
KW  - Pharmacogenetics
KW  - Pharmacokinetics
KW  - Safety
KW  - Infant, Newborn
KW  - Ibuprofen
KW  - Acetaminophen
KW  - Gestational Age
KW  - Ductus Arteriosus
KW  - Pharmacogenetics
TI  - Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol.
TY  - research article
VL  - 8
ER  -